Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function

Journal of Virology

Volumn 74, Issue 15, 2000, Pages 6866-6874

  Mahieux, Renaud ^a   Pise Masison, Cynthia A ^a   Lambert, Paul F ^a   Nicot, Christophe ^b   De Marchis, Laura ^a   Gessain, Antoine ^c   Green, Patrick ^d   Hall, William ^e   Brady, John N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c INSTITUT PASTEUR   (France)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GAMMA IRRADIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; GAMMA RAYS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; JURKAT CELLS; PHOSPHORYLATION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033912934     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.15.6866-6874.2000     Document Type: Article

References (51)

1. Akagi, T., H. Ono, N. Tsuchida, and K. Shimotohno. 1997. Aberrant expression and function of p53 in T-cells immortalized by HTLV-1 Tax-1. FEBS Lett. 406:263-266.
2. Cann, A. J., J. D. Rosenblatt, W. Wachsman, and I. S. Chen. 1989. In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes. J. Virol. 63:1474-1479.
3. Cann, A. J., J. D. Rosenblatt, W. Wachsman, N. P. Shah, and I. S. Chen. 1985. Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature 318:571-574.
4. Cavrois, M., A. Gessain, S. Wain-Hobson, and E. Wattel. 1996. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 12:2419-2423.
5. Cavrois, M., I. Leclercq, O. Gout, A. Gessain, S. Wain-Hobson, and E. Wattel. 1998. Persistent oligoclonal expansion of human T-cell leukemia virus type I-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 17:77-82.
6. Cereseto, A., F. Diella, J. C. Mulloy, A. Cara, P. Michieli, R. Grassmann, G. Franchini, and M. E. Klotman. 1996. p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood 88:1551-1560.
7. Chen, I. S., D. J. Slamon, J. D. Rosenblatt, N. P. Shah, S. G. Quan, and W. Wachsman. 1985. The x gene is essential for HTLV replication. Science 229:54-58.
8. Cimarelli, A., C. A. Duclos, A. Gessain, C. Casoli, and U. Bertazzoni. 1996. Clonal expansion of human T-cell leukemia virus type II in palients with high proviral load. Virology 223:362-364.
9. Cimarelli, A., C. A. Duclos, A. Gessain, E. Cattaneo, C. Casoli, M. Biglione, P. Mauclere, and U. Bertazzoni. 1995. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Ameridians. J. Acquir. Immune. Defic. Syndr. Hum. Retroviril. 10:198-204.
10. Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473.
11. Eiraku, N., P. Novoa, F. da Costa, C. Monken, R. Ishak, S. W. Zhu, R. Lorenco, M. Ishak, V. Azvedo, J. Guerreiro, M. P. de Oliveira, P. Loureiro, N. Hammerschlak, S. Ijichi, and W. M. Hall. 1996. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J. Virol. 70:1481-1492.
12. Fouchard, N., B. Flageul, M. Bagot, M. F. Avril, O. Hermine, F. Sigaux, H. Merle-Beral, X. Troussard, J. F. Delfraissy, and G. de The. 1995. Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. Leukemia 9:2087-2092.
13. Gallo, D., L. M. Penning, and C. V. Hanson. 1991. Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method. J. Clin. Microbiol. 29:2345-2347.
14. Gartenhaus, R. B., and P. Wang. 1995. Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia 9:2082-2086.
15. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis, Lancet ii:407-410.
16. Gessain, A., A. Louie, O. Gout, R. C. Gallo, and G. Franchini. 1991. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. J. Virol. 65:1628-1633.
17. Gessain, A., P. Mauclere, A. Froment, M. Biglione, J. Y. Le Hesran, F. Tekaia, J. Millan, and G. de The. 1995. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc. Natl. Acad. Sci. USA 92:4041-4045.
18. Hall, W. W., R. Ishak, S. W. Zhu, P. Novoa, N. Eiraku, H. Takahashi, M. da C. Ferreira, V. Azevedo, M. O. Ishak, O. da C. Ferreira, C. Monken, and T. Kurata. 1996. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S204-S214.
19. Hall, W. W., H. Takahashi, C. Liu, M. H. Kaplan, O. Scheewind, S. Ijichi, K. Nagashima, and R. C. Gallo. 1992. Multiple isolates and characteristics of human T-cell leukemia virus type II. J. Virol. 66:2456-2463.
20. Heneine, W., W. M. Switzer, M. Busch, R. F. Khabbaz, and J. E. Kaplan. 1995. Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group. J. Clin. Microbiol. 33:3260-3263.
21. Hjelle, B., R. Mills, S. Swenson, G. Mertz, C. Key, and S. Allen. 1991. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J. Infect. Dis. 163: 435-440.
22. Ijichi, S., M. B. Ramundo, H. Takahashi, and W. W. Hall. 1992. In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J. Exp. Med. 176:293-296.
23. Kalyanaraman, V. S., M. G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Golde, and R. C. Gallo. 1982. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571-573.
24. Kalyanaraman, V. S., M. G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Golde, and R. C. Gallo. 1982. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571-573.
25. Lairmore, M. D., S. Jacobson, F. Gracia, B. K. De, L. Castillo, M. Larreategui, B. D. Roberts, P. H. Levine, W. A. Blattner, and J. E. Kaplan. 1990. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc. Natl. Acad. Sci. USA 87:8840-8844.
26. Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-in-duced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:8852-8860.
27. Murphy, E. L. 1996. The clinical epidemiology of human T-lymphotropic virus type II (HTLV-II). J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S215-S219.
28. Murphy, E. L., J. W. Engstrom, K. Miller, R. A. Sacher, M. P. Busch, and C. G. Hollingsworth. 1993. HTLV-II associated myelopathy in 43-year-old woman. REDS Investigators. Lancet 341:757-758.
29. Murphy, E. L., R. Mahieux, G. de The, F. Tekaia, D. Ameti, J. Horton, and A. Gessain. 1998. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO. Virology 242:425-434.
30. Pardi, D., J. E. Kaplan, J. E. Coligan, T. M. Folks, and R. B. Lal. 1993. Identification and characterization of an extended Tax protein in human T-cell lymphotropic virus type II subtype b isolates. J. Virol. 67:7663-7667.
31. Pise-Masison, C. A., K. S. Choi, M. Radonovich, J. Dittmer, S. J. Kim, and J. N. Brady. 1998. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J. Virol. 72:1165-1170.
32. Pise-Masison, C. A., M. Radonovich, K. Sakaguchi, E. Appella, and J. N. Brady. 1998. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J. Virol. 72:6348-6355.
33. Pise-Masison, C. A., R. Mahieux, H. Jiang, M. Ashcroft, M. Radonovich, J. Duvall, C. Guillerm, and J. N. Brady. 2000. Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-κB pathway and is dependent upon phosphorylation. Mol. Cell. Biol. 20:3377-3386.
34. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
35. Prives, C., and J. J. Manfredi. 1993. The p53 tumor suppressor protein: meeting review. Genes Dev. 7:529-534.
36. Reid, R. L., P. F. Lindholm, A. Mireskandari, J. Dittmer, and J. N. Brady. 1993. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 8:3029-3036.
37. Rosenblatt, J. D., A. J. Cann, D. J. Slamon, I. S. Smalberg, N. P. Shah, J. Fujii, W. Wachsman, and I. S. Chen. 1988. HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science 240:916-919.
38. Ross, T. M., A. C. Minella, Z. Y. Fang, S. M. Pettiford, and P. L. Green. 1997. Mutational analysis of human T-cell leukemia virus type 2 Tax. J. Virol. 71:8912-8917.
39. Ross, T. M., S. M. Pettiford, and P. L. Green. 1996. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
40. Sakaguchi, K., J. E. Herrera, S. Saito, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831-2841.
41. Semmes, O. J., F. Majone, C. Cantemir, L. Turchetto, B. Hjelle, and K. T. Jeang. 1996. HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 217:373-379.
42. Suzuki, T., M. Uchida-Toita, and M. Yoshida. 1999. Tax protein of HTLV-I inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA elements of E-box or p53 binding site. Oncogene 18:4137-4143.
43. Switzer, W. M., S. M. Owen, D. A. Pieniazek, V. R. Nerurkar, E. Duenas-Barajas, W. Heneine, and R. B. Lal. 1995. Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb. Virus Genes 10:153-162.
44. Switzer, W. M., D. Pieniazek, P. Swanson, H. H. Samdal, V. Soriano, R. F. Khabbaz, J. E. Kaplan, R. B. Lal, and W. Heneine. 1995. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J. Virol. 69:621-632.
45. Tajima, K., and T. Kuroishi. 1985. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn. J. Clin. Oncol. 15:423-430.
46. Tanaka, Y., M. Hayashi, S. Takagi, and O. Yoshie. 1996. Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax-1 and Tax-2 of human T-cell leukemia viruses. J. Virol. 70:8508-8517.
47. Tarsis, S. L., M. T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks. 1998. Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2. J. Virol. 72:841-846.
48. Vandamme, A. M., M. Salemi, M. Van Brussel, H. F. Liu, K. Van Laethem, M. Van Ranst, L. Michels, J. Desmyter, and P. Goubau. 1998a. African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J. Virol. 72:4327-4340.
49. Van Orden, K., H. A. Giebler, I. Lemasson, M. Gonzales, and J. K. Nyborg. 1999. Binding of p53 to the KIX domain of CREB binding protein. J. Biol. Chem. 274:26321-26328.
50. Wattel, E., M. Cavrois, A. Gessain, and S. Wain-Hobson. 1996. Clonal expansion of infected cells: a way of life for HTLV-I. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S92-S99.
51. Yamato, K., T. Oka, M. Hiroi, Y. Iwahara, S. Sugito, N. Tsuchida, and I. Miyoshi. 1993. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells. Jpn. J. Cancer Res. 84:4-8.